breast cancer stage Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)

Unknown (1)

Observational (1)

Pierre Fabre Pharma GmbH (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadbreast neoplasm

I am/have/hadHER2

I am/have/haderbb1

I am/have/hadbreast cancer staging

I am/have/hadepidermal growth factor receptor

I am/have/hadepidermal growth factor

I am/have/hadbreast cancer stage

I am/have/hadstage i breast cancer

I am/have/hadbreast cancer

I am/have/hadcancer

I am/have/haderbb2

added new label for I am/have/had

more

I am looking for

I am looking forneratinib

I am looking forhuman epidermal growth factor

I am looking forblockade

I am looking forgrowth factor

I am looking foradjuvant

I am looking forepidermal growth factor

I am looking fortrastuzumab

I am looking forimmunostimulant

I am looking forerbb2

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 100s
Observational Study
For Females
Family Medicine
Recruiting

Real-life Pan-HER-blockade With Neratinib

ELEANOR - designed as a prospective, longitudinal, non-interventional study (NIS) - will investigate real-world use of neratinib and its treatment management in patients with HR-positive, HER2-overexpressing/amplified breast cancer stage I-III having completed adjuvant trastuzumab-based therapy less than one year ago. Data from this study will contribute to a deeper understanding …

breast cancer staging

growth factor

epidermal growth factor

trastuzumab

human epidermal growth factor

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.